换一批
换一批A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
作者：
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);阿尔茨海默病(Alzheimer Disease);脑(Brain);脑图(Brain Mapping);疾病恶化(Disease Progression);双盲法(Double-Blind Method);女(雌)性(Female);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);葡萄糖(Glucose);人类(Humans);图像处理, 计算机辅助(Image Processing, Computer-Assisted);磁共振成像(Magnetic Resonance Imaging);男(雄)性(Male);中年人(Middle Aged);正电子发射断层显像术(Positron-Emission Tomography);噻唑烷二酮类(Thiazolidinediones);治疗结果(Treatment Outcome)
DOI
10.3233/JAD-2010-100939
PMID
20930300
发布时间
2024-05-15
- 浏览8
Journal of Alzheimer's disease
1241-56页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
